Emerging markets—a $284 billion opportunity for pharma companies?

Emerging markets have long held enormous appeal for pharma companies—and for good reason.

See on www.accenture.com

Unknown's avatar

Kenneth Carnesi holds a Juris Doctor degree from New York Law School and a Professional Certificate in International Banking from Harvard Law School. Kenneth Carnesi is the Director of Operations and Government Sales at Anaptyx LLC and sits on the Boards of The Lazarus Organization, Monkeetech LLC and MG Madison Phillips, Inc. Mr. Carnesi has also founded CICG - Carnesi International Consulting Group, a company specializing in strategy consulting to small to mid-size businesses.

Posted in Uncategorized

Leave a comment